Profil
Yi Liang served as Vice President-Oncology at Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd.
and Vice President at AstraZeneca Pharmaceuticals Co., Ltd.
Prior to that, he was the Chief Commercial Officer & President-Greater China at Zai Lab Ltd.
from 2018 to 2024.
Dr. Liang holds an MBA from China Europe International Business School and a doctorate from Fudan University.
Anciens postes connus de Yi Liang
| Sociétés | Poste | Fin |
|---|---|---|
| ZAI LAB LIMITED | Corporate Officer/Principal | 30/04/2024 |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. | Corporate Officer/Principal | - |
AstraZeneca Pharmaceuticals Co., Ltd.
 AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The company believes in the power of science and considers it a top priority in all of its work. | Corporate Officer/Principal | - |
Formation de Yi Liang
| Fudan University | Doctorate Degree |
| China Europe International Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ZAI LAB LIMITED | Health Technology |
| Entreprise privées | 2 |
|---|---|
AstraZeneca Pharmaceuticals Co., Ltd.
AstraZeneca Pharmaceuticals Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca Pharmaceutical Co., Ltd. is a Chinese global biopharmaceutical company driven by innovation. Based in Shanghai, China. The company believes in the power of science and considers it a top priority in all of its work. | Health Technology |
| Bristol-Myers Squibb (China) Pharmaceuticals Co. Ltd. |
